Ocular Therapeutix (OCUL) Asset Utilization Ratio (2014 - 2026)
Ocular Therapeutix's (OCUL) Asset Utilization Ratio came in at 0.07 for Q2 2026, down 43.9% from 0.13 a year earlier but up 9.8% from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Asset Utilization Ratio (2014 - 2026) Analysis & Trends
For FY2025, Ocular Therapeutix's Asset Utilization Ratio stood at 0.08, down 54.3% from FY2024.
- In prior years, Ocular Therapeutix's Asset Utilization Ratio was 0.18 in FY2024 (-38.4%), 0.29 in FY2023 (+0.2%), 0.29 in FY2022 (+55.9%) and 0.19 in FY2021 (+82.5%).
- Quarterly Asset Utilization Ratio has run from a low of 0.07 in Q1 2026 to a high of 0.43 in Q2 2023 over five years.
- On a year-over-year basis, Asset Utilization Ratio has declined in each of the last three quarters, with an average decline of 30.3% over the last eight quarters.
- The strongest year-over-year quarter for Asset Utilization Ratio in the past five years was Q1 2022, with growth of 186.9%; the weakest was Q2 2024, with a decline of 73.4%.
- According to Business Quant data, Asset Utilization Ratio for the three prior quarters was 0.07 (Q1 2026), 0.09 (Q4 2025) and 0.13 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 0.47 |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn | 0.07 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.07 |
| Mar 31, 2026 | 0.07 |
| Dec 31, 2025 | 0.09 |
| Sep 30, 2025 | 0.13 |
| Jun 30, 2025 | 0.13 |
| Mar 31, 2025 | 0.14 |
| Dec 31, 2024 | 0.13 |
| Sep 30, 2024 | 0.12 |
| Jun 30, 2024 | 0.12 |
| Mar 31, 2024 | 0.15 |
| Dec 31, 2023 | 0.28 |
| Sep 30, 2023 | 0.41 |
| Jun 30, 2023 | 0.43 |
| Mar 31, 2023 | 0.37 |
| Dec 31, 2022 | 0.33 |
| Sep 30, 2022 | 0.30 |
| Jun 30, 2022 | 0.28 |
| Mar 31, 2022 | 0.25 |
| Dec 31, 2021 | 0.21 |
| Sep 30, 2021 | 0.17 |
API Access
Ocular Therapeutix Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();